{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T07:13:45Z","timestamp":1675754025044},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.4938","type":"journal-article","created":{"date-parts":[[2015,10,31]],"date-time":"2015-10-31T22:08:57Z","timestamp":1446329337000},"page":"2753-2758","source":"Crossref","is-referenced-by-count":5,"title":["Diffuse Leukoencephalopathy Associated with Dialysis Disequilibrium Syndrome"],"prefix":"10.2169","volume":"54","author":[{"given":"Ryuichiro","family":"Hayashi","sequence":"first","affiliation":[{"name":"Department of Neurology, Yokohama Municipal Citizen's Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kozo","family":"Kitazawa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Yokohama Municipal Citizen's Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Sanada","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Yokohama Municipal Citizen's Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Yokohama Municipal Citizen's Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Ohkoshi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Yokohama Municipal Citizen's Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Katsumata","sequence":"additional","affiliation":[{"name":"Department of Radiology, Yokohama Municipal Citizen's Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yokohama Municipal Citizen's Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Patel N, Dalal P, Panesar M. Dialysis disequilibrium syndrome: a narrative review. Semin Dial 21: 493-498, 2008.","DOI":"10.1111\/j.1525-139X.2008.00474.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sheth KN, Wu GF, Messé SR, Wolf RL, Kasner SE. Dialysis disequilibrium: another reversible posterior leukoencephalopathy syndrome? Clin Neurol Neurosurg 105: 249-252, 2003.","DOI":"10.1016\/S0303-8467(03)00039-8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bagshaw SM, Peets AD, Hameed M, Boiteau PJ, Laupland KB, Doig CJ. Dialysis Disequilibrium Syndrome: brain death following hemodialysis for metabolic acidosis and acute renal failure - a case report. BMC Nephrol 5: 9, 2004.","DOI":"10.1186\/1471-2369-5-9"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shaikh N, Louon A, Hanssens Y. Fatal dialysis disequilibrium syndrome: A tale of two patients. J Emerg Trauma Shock 3: 300, 2010.","DOI":"10.4103\/0974-2700.66555"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Chang CH, Hsu KT, Lee CH, et al. Leukoencephalopathy associated with dialysis disequilibrium syndrome. Ren Fail 29: 631-634, 2007.","DOI":"10.1080\/08860220701392306"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Agildere AM, Benli S, Erten Y, Coskun M, Boyvat F, Ozdemir N. Osmotic demyelination syndrome with a dysequilibrium syndrome: reversible MRI findings. Neuroradiology 40: 228-232, 1998.","DOI":"10.1007\/s002340050572"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tarhan NC, Agildere AM, Benli US, Ozdemir FN, Aytekin C, Can U. Osmotic demyelination syndrome in end-stage renal disease after recent hemodialysis: MRI of the brain. Am J Roentgenol 182: 809-816, 2004.","DOI":"10.2214\/ajr.182.3.1820809"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Soomro A, Al Bahri R, Alhassan N, Hejaili FF, Al Sayyari AA. Posterior reversible encephalopathy syndrome with tactile hallucinations secondary to dialysis disequilibrium syndrome. Saudi J Kidney Dis Transpl 25: 625-629, 2014.","DOI":"10.4103\/1319-2442.132216"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Pirker A, Kramer L, Voller B, Loader B, Auff E, Prayer D. Type of edema in posterior reversible encephalopathy syndrome depends on serum albumin levels: an MR imaging study in 28 patients. Am J Neuroradiol 32: 527-531, 2011.","DOI":"10.3174\/ajnr.A2332"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Graham BR, Pylypchuk GB. Posterior reversible encephalopathy syndrome in an adult patient undergoing peritoneal dialysis: a case report and literature review. BMC Nephrol 15: 10, 2014.","DOI":"10.1186\/1471-2369-15-10"},{"key":"11","unstructured":"11. Casey SO, Truwit CL. Pontine reversible edema: A newly recognized imaging variant of hypertensive encephalopathy? Am J Neuroradiol 21: 243-245, 2000."},{"key":"12","unstructured":"12. Eichler FS, Wang P, Wityk RJ, Beauchamp NJ Jr, Barker PB. Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome. Am J Neuroradiol 23: 833-837, 2002."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. Am J Neuroradiol 28: 1320-1327, 2007.","DOI":"10.3174\/ajnr.A0549"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Attur RP, Kandavar R, Kadavigere R, Baig WW. Dialysis disequilibrium syndrome presenting as a focal neurological deficit. Hemodial Int 12: 313-315, 2008.","DOI":"10.1111\/j.1542-4758.2008.00272.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yetim E, Gocmen R, Topcuoglu MA, Arsava EM. Reversible white matter edema in dialysis disequilibrium syndrome. J Neuroradiol 42: 247-249, 2015.","DOI":"10.1016\/j.neurad.2014.10.003"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Galons JP, Trouard T, Gmitro AF, Lien YH. Hemodialysis increases apparent diffusion coefficient of brain water in nephrectomized rats measured by isotropic diffusion-weighted magnetic resonance imaging. J Clin Invest 98: 750-755, 1996.","DOI":"10.1172\/JCI118847"},{"key":"17","unstructured":"17. Chen CL, Lai PH, Chou KJ, Lee PT, Chung HM, Fang HC. A preliminary report of brain edema in patients with uremia at first hemodialysis: evaluation by diffusion-weighted MR imaging. Am J Neuroradiol 28: 68-71, 2007."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ohara S, Hayashi R, Hata S, Itoh N, Hanyu N, Yamamoto K. Leukoencephalopathy induced by chemotherapy with tegafur, a 5-fluorouracil derivative. Acta Neuropathol 96: 527-531, 1998.","DOI":"10.1007\/s004010050929"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Stewart MW. The expanding role of vascular endothelial growth factor inhibitors in ophthalmology. Mayo Clin Proc 87: 77-88, 2012.","DOI":"10.1016\/j.mayocp.2011.10.001"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Thompson EM, Frenkel EP, Neuwelt EA. The paradoxical effect of bevacizumab in the therapy of malignant gliomas. Neurology 76: 87-93, 2011.","DOI":"10.1212\/WNL.0b013e318204a3af"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Seet RC, Rabinstein AA. Clinical features and outcomes of posterior reversible encephalopathy syndrome following bevacizumab treatment. QJM 105: 69-75, 2012.","DOI":"10.1093\/qjmed\/hcr139"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Abbas O, Shamseddin A, Temraz S, Haydar A. Posterior reversible encephalopathy syndrome after bevacizumab therapy in a normotensive patient. BMJ Case Rep 2013: 2013.","DOI":"10.1136\/bcr-2012-007995"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Sato Y, Hirose M, Inoue Y, et al. Reversible posterior leukoencephalopathy syndrome after blood transfusion in a patient with end-stage renal disease. Clin Exp Nephrol 15: 942-947, 2011.","DOI":"10.1007\/s10157-011-0515-0"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/21\/54_54.4938\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T05:09:24Z","timestamp":1567314564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/21\/54_54.4938\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":23,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.4938","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}